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Abstract
Background: The relationship between nutrition and Crohn’s disease (CD) is complex and involves several
therapeutic possibilities including: nutrition treatment for malnourished patients, optimization of growth and
development, prevention of osteoporosis, first-line therapy for active disease, and maintenance of disease
remission. In children and adolescents with CD, malnutrition is a common problem that adversely affects the
prognosis. In at-risk adolescent CD patients, it is important to assess body composition, food intake, energy
expenditure, nutrient balance and serum levels of nutrients before planning interventions for this population.
The aim of this study was to provide a snapshot of the nutritional status of adolescents with CD in Brazil.
Methods: We prospectively selected 22 patients with mildly to moderately active CD, 29 patients with inactive CD
and 35 controls (first-degree relatives of and in the same age bracket as the CD patients). The age range of participants
was between 13.2 and 19.4 years old. We collected anthropometric data including weight, height, and body mass
index (BMI), which were expressed as Z scores: weight-for-age, height-for-age and BMI-for-age, respectively, as
well as using bioimpedance to determine body composition and assessing the Tanner stage. We also assessed
macronutrients and micronutrients (serum levels and dietary intake of both). We used the chi-square test to determine
whether any of the studied variables were associated with inactive or active CD. The level of significance was set at 5 %
(p < 0.05). We have written informed parental consent for participation for any minors and written informed consent
for any participants that were adults.
Results: The mean values for lean body mass, Tanner stage, height-for-age Z score and BMI-for-age Z score were lower
in the active CD group than in the inactive CD and control groups (p < 0.05 for both). Compared with the controls, the
CD patients showed significant differences in terms of the quality of dietary intake (particularly in caloric intake, dietary
protein intake, dietary fiber intake, and micronutrient intake), which were reflected in the serum levels of nutrients,
mainly vitamins A and E (p < 0.05).
Conclusions: Adolescents with CD (including those with mildly to moderately active or inactive disease) have
a nutritional risk, which makes it important to conduct nutritional assessments in such patients.
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Background
In approximately 25–30 % of all patients with CD, the
onset of the disease occurs before 20 years of age. Be-
cause the peak onset of pediatric inflammatory bowel
disease (IBD) occurs in late adolescence, this event may
turn out to be a potent influence on puberty and growth
development [1–3].
In this setting, the most specific complication of
pediatric CD is growth deficit, which is caused by a
combination of inadequate caloric intake, increased loss
of calories and persistent active inflammation of the in-
testinal mucosa [4]. In such patients, excessive weight
loss and malnutrition result in abnormal anthropometric
measurements. Therefore, in patients with IBD (princi-
pally in those with CD), body mass indices (BMIs) and
weights are below normal when compared with refer-
ence values or with the values reported for healthy
controls [5, 6]. Particularly at this age, micronutrient
deficiencies can influence the progression and clinical
outcome of IBD, affecting the immune and antioxi-
dant defense systems, as well as tissue repair, growth,
and bone mineralization [7].
The presence of nutritional changes in adolescents
with CD has not always been adequately investigated
or given sufficient attention by physicians. Nutritional
changes in such patients are directly influenced by
the society in which they live and the treatment given.
Therefore, data from other countries cannot be extrapo-
lated to Brazil. This, together with the lack of studies
examining this issue in the country, motivated us to con-
duct the present study.
Methods
The study population consisted of patients with a
confirmed diagnosis of CD [1] undergoing regular
treatment at the Clinical Gastroenterology Outpatient
Clinic of the University of São Paulo School of Medicine
Hospital das Clínicas, located in the city of São Paulo,
Brazil, between January 2007 and March 2011. The con-
trols were selected among individuals who were first-
degree relatives of the CD patients and were in the same
age bracket as the latter. The age range of participants was
between 13.2 and 19.4 years old. We excluded individuals
with intestinal diseases or other diseases affecting the nu-
tritional status. First-degree relatives were used as controls
because their cultural and environmental influences were
the same as those of their CD counterparts; that is, they
had the same dietary habits and lived in the same city. In
addition, adherence to the study protocol was higher be-
cause the controls were relatives of the CD patients. For
the CD and control groups, the exclusion criteria were as
follows: diagnosis of infection, cancer, severe psychiatric
disorder, hypothyroidism, hyperthyroidism, corticosteroid
usage in the last two months and pregnancy.
In order to classify CD in terms of its characteristics
and severity, we used the Paris classification (a pediatric
modification of the Montreal classification of IBD) [8]
and the Pediatric Crohn’s Disease Activity Index [9].
The Research Ethics Committee of the University of
Sao Paulo School of Medicine Hospital das Clínicas, in
the city of Sao Paulo, Brazil, approved the research
project.
We have written informed parental consent for partici-
pation for any minors and written informed consent for
any participants that were adults.
Anthropometry
Anthropometric variables, such as weight, height, and
BMI, as well as bioimpedance, were determined in ac-
cordance with standardized methods [10, 11]. Weight
and BMI were expressed as Z scores using the World
Health Organization (WHO) program AnthroPlus, ver-
sion 1.0.4 (http://www.who.int/growthref/tools/en/), and
sexual maturation was classified according to the Tanner
stage [12], as well as being ranked as pubertal or pre-
pubertal according to the recommendations of the
WHO [11].
In the bioimpedance analysis, we used a tetrapolar
whole-body analyzer (BIA 310; Biodynamics Corpor-
ation, Seattle, WA, USA). According to Woodrow [13],
the use of bioimpedance analysis for assessing body
composition is a rapid, noninvasive and relatively inex-
pensive method for estimating the amount of body fat,
as well as being a portable and easily applicable method.
Dietary intake
Dietary intake was assessed by means of a 7-day food
diary [14]. The food diary covered the 7 days that
preceded the medical consultation, was filled out by
patients themselves or their legal guardians, and was
reviewed upon delivery in order to minimize procedural
errors.
The quantitative variables studied were total energy
intake, consumption of macronutrients (carbohydrates,
lipids and proteins), and consumption of fiber and
micronutrients (vitamins A, B12, C, D, E, folic acid,
calcium, iron, potassium, magnesium, sodium and zinc).
The calculations were made with the software DietPro,
version 5.7i (A. S. Sistemas, Viçosa, Brazil).
To determine the basal metabolic rate for each adoles-
cent, we used the Harris-Benedict equation [15], cor-
rected for gender, age, weight and coefficient of degree
of physical activity during the week, deemed as minimal
effort for all patients studied. Considering 100 % of diet-
ary reference intakes (DRIs) [16], we ranked total energy
intake and micronutrient consumption as below or
above the recommended levels. Macronutrient intake
was analyzed according to the recommendations of the
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WHO and the United Nations Food and Agriculture
Organization, thus categorized as below the lower limit,
above the upper limit or within the recommended
range [17].
Biochemical parameters
Blood samples were collected for analysis of serum levels
of the following: vitamins A, B12, and E, as well as 25-
hydroxyvitamin D, folic acid, iron, ionized calcium, zinc,
magnesium, potassium, copper, albumin, hemoglobin,
cholesterol and triglycerides. The values obtained were
analyzed against the reference values adopted by the
Central Laboratory of the University of São Paulo School
of Medicine Hospital das Clínicas.
Statistical analysis
We used the chi-square test in order to investigate pos-
sible associations between the studied variables and the
three groups (inactive CD, active CD, and control). The
level of significance was set at 5 % (p < 0.05). The food
consumption data were processed with the DietPro
software, after which they were analyzed with the pro-
grams Microsoft Excel, Epi Info, version 6.04, and the
Statistical Package for the Social Sciences, version 13.0
(SPSS Inc., Chicago, IL, USA).
Results
The present study included 86 individuals: 22 in the ac-
tive CD group (patients with mildly to moderately active
CD), 29 in the inactive CD group, and 35 in the control
group. The mean (SD) PCDAI scores (0–100 scale) for
patients with inactive, mild, and moderate disease were
7.0 (7.1), 18.3 (10.8), 26.2 (11.4), respectively. The demo-
graphic characteristics of the study sample are summa-
rized in Table 1. The clinical characteristics, location
and behavior of the CD are summarized in Table 2.
Patients with inactive CD showed an increase of the me-
dian duration of the disease, although the difference was
not significant. In terms of the location affected, simul-
taneous involvement of the ileum and colon was most
common, followed by isolated involvement of the ileum
and isolated involvement of the colon. The most common
types of CD were the non-stricturing non-penetrating type
and the penetrating type.
As can be seen in Table 3, the mean Z scores for
height-for-age and BMI-for-age were higher in the active
CD group than in the inactive CD group, as well as
being higher in the inactive CD group than in the
control group; the differences among the groups were
significant. When compared individually, 2 (9.1 %) of
the patients with active CD and 1 (3.4 %) of those
with inactive CD had short stature (height-for-age Z
score < − 2). In addition, 7 (31.8 %) of the patients
with active CD and 3 (10.3 %) of those with inactive
CD were malnourished (BMI-for-age Z score < − 2).
The deficit of lean body mass in relation to the fat
compartment was more pronounced in the active CD
group than in the inactive CD and control groups. It
is of note that some (4.2 %) of the CD patients had a
BMI-for-age Z score > 2 standard deviations, which
characterized them as overweight.
Regarding the Tanner stage of sexual maturation, de-
layed puberty was observed in 22.7 % of the active CD
group patients, compared with only 6.9 % of those in the
inactive CD group; the difference between the two
groups was significant. None of the individuals in the
control group presented delayed puberty.
The patients that made the greatest use of azathio-
prine were those with active disease (95.4 %). At the
time of this study, none of the patients were using pred-
nisone. Antibiotics (metronidazole and ciprofloxacin)
were used by approximately one-third of the active CD
group patients and half of the inactive CD group pa-
tients. Approximately 23 % of the patients with active
CD were using infliximab (Table 4).
Total energy intake was lower than the DRIs in 50 %
of the adolescents with active CD, in 3.5 % of those with
inactive CD, and in 5.7 % of those in the control group
(Fig. 1). Macronutrient intake was found to be below the
DRIs in 9.1 % of the patients with active CD and in
5.7 % of the controls; no decrease in carbohydrate intake
was observed in the patients with inactive CD. Protein
Table 1 Sociodemographic characteristics of Crohn’s disease patients and controls
Characteristic Active CD (Group I) Inactive CD (Group II) Control (Group III) G1 G2 G3
(n = 22) (n = 29) (n = 35)
Age (years), mean ± SD 16.4 ± 2.5 17.3 ± 2.19 15.5 ± 2.31 NS NS NS
Gender
Male, n (%) 12 (54.5) 16 (55.2) 22 (62.8) NS NS NS
Female, n (%) 10 (45.5) 13 (44.8) 13 (37.2) NS NS NS
Race
White, n (%) 20 (90.9) 26 (89.6) 32 (91.3) NS NS NS
Non-White, n (%) 2 (9.1) 3 (10.4) 3 (8.7) NS NS NS
CD Crohn’s disease, SD: standard deviation, G1 group I vs. group II, G2 group I vs. group III, G3 group II vs. group III, NS not significant
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intake was found to be below the DRIs in all three
groups, being far lower in the active CD group than in
the inactive CD and control group (68.2 % vs. 17.2 %
and 14.3 % below the DRIs, respectively). Lipid intake
was also found to be below the DRIs, principally in those
with active CD (18.2 % below the DRIs). Dietary fiber in-
take was low in all groups, being particularly low in the
two groups of patients with CD (Fig. 1).
Figure 2 shows the percentage of individuals with a
mineral intake below the recommended level. Dietary
calcium, iron, potassium, magnesium, selenium, and
zinc intake was lowest in the active CD group, followed
by the inactive CD and control group; the differences
among the three groups were statistically significant
(p < 0.05 for all; Fig. 2).
Vitamin intake was lower than recommended in at
least 75 % of the patients with active CD (Fig. 3).
Vitamin intake was lower in the active CD group
than in the inactive CD group, as well as being lower
in the CD groups than in the control group; the dif-
ferences were statistically significant (p < 0.05).
In comparison with the controls, the patients with CD
were deficient in serum ferritin and serum albumin. In
addition, serum albumin levels were lowest in the pa-
tients in remission; the difference between that group of
patients and the remaining two groups showed a trend
Table 2 Clinical characteristics, location, and behavior of the disease in patients with active and inactive Crohn’s disease, based on
Levine et al. [8]
Active CD Inactive CD G1
Mean time of disease duration (years) ± SD 1.14 ± 1.06 2.83 ± 3.34 NS
Mean age of onset of symptoms (years) ± SD 14.4 ± 3.7 14.1 ± 3.7 NS
Mean age at diagnosis (years) ± SD 15.6 ± 2.38 14.5 ± 3.66 NS
Mean PCDAI ± SD 18.3 ± 10.8 26.2 ± 11.4 7.0 ± 7.1
Location, n (%)
L1(distal 1/3 ileum/limited cecal disease) 8 (36) 11 (38) NS
L2(colonic) 3 (14) 7 (24) NS
L3(ileocolonic) 11 (50) 11 (38) NS
L4 a (upper disease proximal to ligament of Treitz) 0 0
L4b (upper disease distal to ligament of Treitz and proximal to distal 1/3 ileum 0 0
Behavior, n (%)
B1: non-stricturing non-penetrating 16 (73) 25 (86) NS
B2: structuring 2 (9) 0 NS
B3: penetrating 4 (18) 4 (14) NS
B2B3: both penetrating and stricturing disease, either at the same or different times 0 0
p: perianal disease modifier 2 (9) 0 NS
CD Crohn’s disease, SD standard deviation, G1 group I vs. group II
Table 3 Anthropometric evaluation of active and inactive Crohn’s disease patients and controls
Variable Active CD Inactive CD Control G1 G2 G3
(Group I) (Group II) (Group III)
(n = 22) (n = 29) (n = 35)
Z score
Ha, mean ± SD −0.41 ± 0.90 −0.15 ± 0.92 0.24 ± 0.99 * * *
BMIa, mean ± SD −1.29 ± 1.64 0.01 ± 1.18 0.37 ± 1.18 * * *
Bioimpedance analysis
BF (%), mean ± SD 23 ± 0.08 21 ± 0.05 24 ± 0.04 NS NS NS
LBM (%), mean ± SD 74 ± 0.08 79 ± 0.05 76 ± 0.04 * * NS
Tanner staging
Delayed puberty, n (%) 5 (22.7) 2 (6.9) - * * NS
CD Crohn’s disease, G1 group I vs. group II, G2 group I vs. group III, G3 group II vs. group III, Ha height-for-age, BMIa body mass index-for-age, BF body fat, LBM
lean body mass, NS not significant; *p < 0.05
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toward statistical significance (p < 0.05). Serum ferritin
levels were also lower in the patients in remission with
the difference showing a tendency toward statistical sig-
nificance (p < 0.05 vs. the other groups).
Although calcium and magnesium intake was low, in
comparison with the DRIs, in all three groups, none of
the groups showed serum calcium deficiency or serum
magnesium deficiency (Fig. 4). In the present study, the
most common dietary mineral deficiency was serum iron
deficiency (p < 0.05), being more pronounced in the in-
active CD group than in the active CD group (in con-
trast to what was observed for the remaining minerals).
Serum levels of vitamin A and vitamin E were lower in
the active CD group than in the remaining two groups
(p < 0.05). In contrast, the rate of vitamin B12 deficiency
was highest in the inactive CD group, although the
differences among the groups were not significant
(p > 0.05). None of the groups showed serum vitamin
D deficiency or serum folic acid deficiency (Fig. 5).
We did not find significant differences (p > 0.05) for
the cholesterol and triglycerides levels respectively be-
tween the inactive CD (145.76 ± 3.65 mg/dl; 94.24 ±
7.47 mg/dl), active CD (148.27 ± 2.12 mg/dl; 93.64 ±
5.58 mg/dl) and control group (147.60 ± 3.03 mg/dl;
92.23 ± 6.7 mg/dl). For instance, the hemoglobin results
were lowest in the inactive and active CD group (11.86 ±
0.35 g/dl; 11.87 ± 0.39 g/dl) compared to the control
group (12.15 ± 0.27 g/dl), but not significantly different.
The CD patients investigated in the present study
showed significant changes in body composition and in
the quality of dietary intake (particularly in caloric in-
take, dietary protein intake, dietary fiber intake, and
micronutrient intake), which were reflected in the serum
levels of nutrients, principally vitamins A and E.
Discussion
In the present study, we provided a snapshot of the nutri-
tional status of CD adolescents in Brazil using instruments
Table 4 Distribution of the patients (%) with active or inactive Crohn’s disease according to the drugs that were taken before and
during the study
Drug Before the study G1 During the study G1
Active CD Inactive CD Active CD Inactive CD
n (%) n (%) n (%) n (%)
(Group I) (Group II) (Group I) (Group II)
Azathioprine 22(100) 25(86.2) NS 21(95.4) 18(62.1) *
Sulfasalazine 3(13.6) 3(10.3) NS 2(9.1) 1(3.5) NS
Mesalazine 20(90.9) 15(51.7) * 10(45.4) 16(55.2) NS
Ciprofloxacin 12(54.5) 16(55.2) NS 3(13.6) 12(41) *
Metronidazole 10(45.4) 11(37.9) NS 4(18.2) 2(6.9) NS
Infliximab 8(36.3) 6(20.7) NS 5(23.1) 5(17.2) NS
CD Crohn’s disease, G1 group I vs. group II, NS not significant; *p < 0.05
Fig. 1 Deficiencya in the ingestion of total calories, macronutrients and fiber in patients with active DC, patients with inactive DC and control
individuals. a Percentange of deficiency is based on the recommendations of the World Health Organization and the United Nations Food and
Agriculture Organization [17]. *p < 0.05 vs. inactive CD group; # p < 0.05 vs. control group
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and methods that are available at any health facility where
such patients might be followed. We found that BMI-for-
age and height-for-age were significantly lower in the pa-
tients with CD than in the controls, a finding that was
consistent with those of Burnham et al. [18], who studied
104 children and young adults with CD evaluated an aver-
age of 4 years after the disease had been diagnosed (as was
the case in the present study).
In a similar study, Thayu et al. [19] investigated a sam-
ple of 78 children and adolescents with CD and found
significant changes in growth, pubertal development,
and body composition (in particular, lean body mass
loss) at diagnosis in comparison with the control group,
although they found no differences between the genders.
The deficit of lean body mass persisted throughout the
follow-up period.
In the present study, caloric intake was found to be
lower than recommended in 50 % of the patients with
active CD, in 3.5 % of those with inactive CD, and in
5.7 % of the controls. According to Thomas et al. [20],
during disease exacerbation, caloric intake can decrease
by 20 % from the recommended intake and the energy
deficit can reach 400 kcal per day. Those authors
showed that the mean intake of all micronutrients ex-
cept vitamin B12 was below the DRIs. Likewise, in the
present study, the prevalence of micronutrient deficiency
was higher among the patients with CD than among
those in the control group. In addition, micronutrient
intake was lower in the patients with active CD than in
those with inactive CD.
According to Green et al. [21], dietary intake deficien-
cies are due to major changes in dietary habits occurring
Fig. 2 Percentage of deficiencya in mineral intake in the patients with active DC, patients with inactive DC and control individuals. aPercentange
of deficiency is based on dietary reference intakes [16]. *p < 0.05 vs. inactive CD group; # p < 0.05 vs. control group
Fig. 3 Percentage of deficiencya in vitamin intake in the patients with active DC, patients with inactive DC and control individuals. aPercentage of
deficiency is based on dietary reference intakes [16]. *p < 0.05 vs. inactive CD group; # p < 0.05 vs. control group
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after the diagnosis of CD. The authors observed
qualitative changes in the dietary habits of pediatric
CD patients, who primarily avoided milk and dairy
products, as well as fruits and vegetables (because of
their high fiber content), mainly for fear of triggering
an exacerbation.
Approximately 30 % of the CD patients in our study
showed serum iron deficiency, a finding that was con-
sistent with those of at least two studies [22, 23]. What
surprised us was the fact that the prevalence of iron de-
ficiency was higher in the patients with inactive CD
than in those with active CD. One possible explanation
is that many of the patients with active CD were receiv-
ing iron supplements and the hemoglobin was not sta-
tistically different between these group. In this regard,
the lower iron level observed in the inactive CD group
could be explained with a longer duration of the disease
in comparison with the active group, although the
values were not statistically different.
We also found that patients with inactive and active
CD were deficient in serum albumin in comparison with
the controls, and were lowest in the patients in remis-
sion, probably because the parameter used was only
PCDAI and no calprotectin or endoscopy parameter was
used. In contrast, El-Matary et al. found a significant de-
ficiency of serum albumin in children with active CD
using the PCDAI index which correlated with anti-
Saccharomyces cerevisiae antibody titres [24].
The rates of serum vitamin deficiency were highest
for vitamins A and E, principally in the patients with
active CD (p < 0.05). This finding was consistent with
Bousvaros et al. [25], who found that vitamin A
Fig. 4 Percentage of serum mineral deficiency in the patients with active DC, patients with inactive DC and control individuals
Fig. 5 Percentage of serum vitamin deficiency in the patients with activity CD, inactive CD and control group. *p < 0.05 vs. inactive CD group;
# p < 0.05 vs. control group
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deficiency and vitamin E deficiency were associated with
disease activity. Hoffbrand et al. [26] found changes in
plasma levels of antioxidant vitamins in CD patients
in comparison with patients with ulcerative colitis
and controls.
The limitations of the study included the lack of pre-
albumin; given its shorter half-life than that of albumin,
it is a very good parameter to evaluate nutritional status.
Conclusions
Adolescents with CD, including those with mildly to
moderately active or inactive disease, are at risk for nu-
tritional deficits, which makes it important to conduct
nutritional assessments as part of the routine evalu-
ation of such patients, in order to plan nutritional sup-
port as part of the overall treatment strategy in this
population.
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